Contracts & Pricing October 27, 2022 Stacking Discounts for Best Price, PHS & 340B, HHS Ruling 3 Minute Read Regulatory and legal updates on three significant regulatory topics, including stacking of discounts for best price, PHS and 340B.
Contracts & Pricing September 27, 2022 FSS Public Law, US Territory Inclusion, and Branded Prescription Fee Invoice 4 Minute Read Regulatory and legal updates on four significant regulatory topics, including the Inflation Reduction Act and FSS Public Law updates.
Contracts & Pricing August 29, 2022 The Impact of the Inflation Reduction Act on the Pharmaceutical Industry 4 Minute Read Explore some of the key provisions and timelines of the Inflation Reduction Act for their impact on pharmaceutical manufacturers government pricing and GTN strategies.
Contracts & Pricing August 19, 2022 NDC Format Proposal, Focus on PBMs, False Claims Act 4 Minute Read August's market update is a legislative review of the NDC formal proposal, FTC investigation of PBMs, and the False Claims Act.
Contracts & Pricing July 19, 2022 Legal Review: Medicare Program, 340B, and State Price Updates 6 Minute Read July's market update is a legislative review of 340B contract pharmacy restrictions, new Medicare bills, and SPTR updates.
Channel July 13, 2022 Top Trends in Specialty Network and Service Design 5 Minute Read Benchmarks on specialty networks using our exclusive ICyte channel and patient access data: what specialty networks look like, who's included, and how network sizes vary by therapeutic category.
Contracts & Pricing June 27, 2022 Pharma vs. 340B 4 Minute Read This month’s market update features the latest news detailing the tumultuous relationship between pharma and 340B, including The Supreme Court, HRSA, and insight on how inflation escalates everything.
Contracts & Pricing June 14, 2022 Top Trends in Contracting 6 Minute Read Using exclusive ICyte Benchmarks from over 230 brands across more than 50 manufacturers, we examine the top trends in specialty pharmacy contracting.
Launch Readiness June 7, 2022 Best Practices: Identifying and Avoiding Patient Access Barriers 4 Minute Read Market access leaders from DBV Technologies, Sesen Bio, and Karyopharm Therapeutics discuss strategies to overcome obstacles to patient initiation and adherence.
